Position in TEVA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$1,907,017
+$171,117 QoQ
Shares Held
63,314
+13.8% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $396,096,801 across 26 Drug Manufacturers - Specialty & Generic names. TEVA ranks #6 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
616,050 | $365,305,329 | |
| 2 | ZTS |
Zoetis Inc.
|
140,768 | $16,640,185 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
227,616 | $4,215,448 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
17,277 | $2,276,071 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
43,972 | $2,272,912 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
63,314 | $1,907,017 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
22,495 | $1,706,245 | |
| 8 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
53,738 | $1,052,727 |
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,907,017 | 63,314 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,735,900 | 55,620 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $748,490 | 37,054 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $336,457 | 20,075 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $130,060 | 8,462 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $114,718 | 5,205 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $6,379 | 354 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $8,872 | 546 | Shares | Sole | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||